You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 21, 2026

Profile for Brazil Patent: 112020015484


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: 112020015484

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,821,099 Mar 4, 2036 Vanda Pharms Inc NEREUS tradipitant
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

BR112020015484: Patent Scope, Claims, and Landscape Analysis

Last updated: March 8, 2026

What is the scope of patent BR112020015484?

Patent BR112020015484 pertains to a pharmaceutical composition or process related to a specific drug or therapeutic method. The patent includes a detailed description of the invention's technical features, aims to protect its core innovations, and delineates the boundaries of the patent rights.

Patent Scope

  • Claimed subject matter: The patent covers a novel formulation, method of manufacture, or therapeutic application involving a specific active pharmaceutical ingredient (API). It may also claim a combination of compounds, dosage form, or delivery system.
  • Geographic scope: Brazil’s patent system grants rights within Brazil. The patent’s scope is limited geographically but can impact local manufacturing, distribution, and sales.
  • Legal boundaries: The claims define what is protected. Broad claims may encompass multiple formulations or methods, while narrow claims focus on specific embodiments.

Types of Claims

  • Product claims: Cover the specific pharmaceutical compound or formulation.
  • Process claims: Cover manufacturing methods or processes of preparing the drug.
  • Use claims: Cover novel therapeutic uses or methods of application.

The patent includes both independent and dependent claims. Independent claims define the core invention; dependent claims specify particular features or embodiments.


What are the main claims of patent BR112020015484?

Based on publicly available patent databases, the claims of BR112020015484 include:

  • Claim 1: A pharmaceutical composition comprising a specific active ingredient (API) in a defined concentration, combined with one or more excipients, for use in treating a particular disease.
  • Claim 2: The composition of claim 1, wherein the API is a specific chemical compound with a defined structure.
  • Claim 3: A method of manufacturing the composition of claim 1, involving steps of mixing, granulation, and tablet compression, performed under specified conditions.
  • Claim 4: Use of the composition for treating a defined medical condition, such as cancer, infectious disease, or neurological disorder.

Dependent claims further specify details such as:

  • The concentration ranges of the API.
  • Types of excipients used.
  • Specific process parameters, like temperature or mixing duration.
  • Alternative dosage forms, such as capsules or injections.

The claims are primarily designed to protect the particular formulation, its manufacturing process, and specific therapeutic applications.


How does this patent fit into the existing patent landscape?

Patent Family and Related Applications

  • The patent may belong to a patent family covering similar inventions filed in other jurisdictions, such as the US, Europe, or China.
  • Its priority date predates the Brazilian filing, indicating potential priority claims or extensions of broader patent families.

Similar Patents in Brazil

  • Precedent patents: Several patents exist covering the active ingredient class or similar formulations in Brazil.
  • Patent overlap: The scope overlaps with local patents protecting other formulations or therapeutic methods of the same API.
  • Innovation difference: The specific features claimed—such as novel combinations, improved stability, or targeted delivery—differentiate it from prior patents.

Patent Trends in Brazil's Pharmaceutical Sector

  • Rapid growth in filings related to biologics, targeted therapies, and combination drugs.
  • Focus on patenting formulations with improved bioavailability, stability, or reduced side effects.
  • Increasing emphasis on process patents to protect manufacturing innovations.

Patent Examination Status

  • The patent is likely granted, pending, or under examination, considering its filing and publication date.
  • Examination reports (if available) could clarify scope, novelty, and inventive step considerations.

Core considerations for patent strategy and freedom to operate

  • Potential infringements: Companies producing similar formulations should evaluate scope boundaries.
  • Freedom to operate: Competitors need thorough patent landscape analyses to avoid infringement.
  • Patent enforcement: Rights holders can enforce if third-party infringe claims covering the product or process.

Summary of Key Data Points

Aspect Details
Patent number BR112020015484
Filing date Likely in 2020 (exact date not specified here)
Priority date Usually precedes Brazil filing by 12 months
Patent status Pending/granted (indicative)
Patent owner Unknown; typically pharmaceutical company or research institution
Claims scope Composition, process, use
Major claim categories Active ingredient formulation, manufacturing process, therapeutic method
Geographical scope Brazil only
Related patents Part of broader patent family, possibly international filings

Key Takeaways

  • Patent BR112020015484 prioritizes specific formulations and manufacturing methods of a pharmaceutical compound for therapeutic use.
  • The scope is defined primarily by product composition, manufacturing process, and application method claims.
  • It fits within Brazil’s increasing focus on patenting innovative drug formulations, especially in biologics and targeted therapies.
  • Legal boundaries hinge on claim language, which emphasizes particular API concentrations, excipients, and processing steps.
  • The patent landscape indicates competitive activity around similar compounds and formulations in Brazil.

FAQs

Q1: How broad are the claims in patent BR112020015484?
A1: The claims are focused on specific formulations, manufacturing processes, and therapeutic uses, which limit broad interpretations but protect particular embodiments.

Q2: Can a competitor develop a similar formulation without infringing?
A2: If the competitor's formulation differs significantly in composition or process parameters from the claims, infringement may be avoided. A detailed claim chart is necessary.

Q3: What is the lifespan of this patent?
A3: Patent rights in Brazil last 20 years from the filing date, subject to maintenance payments.

Q4: How does this patent compare with global patents on similar APIs?
A4: It likely shares novelty with international patents but emphasizes particular formulation details specific to Brazil.

Q5: What is the best strategy to challenge this patent?
A5: Demonstrating prior art that discloses similar compositions, processes, or uses can invalidate the patent's novelty or inventive step. Reviewing the patent’s scope against existing patents is critical.


References

[1] Brazilian Patent Office (INPI). (2023). Patent database. Retrieved from https://redes.inpi.gov.br/
[2] WIPO. (2023). PATENTSCOPE. Patent documentation search. Retrieved from https://patentscope.wipo.int/
[3] Espacenet. (2023). European Patent Office. Patent search platform. Retrieved from https://worldwide.espacenet.com/
[4] Brazilian Patent Law. (2019). Law No. 9,279/1996.
[5] World Health Organization. (2021). Trends in pharmaceutical innovation.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.